Bi-weekly Dosing of ARB-1467 LNP siRNA in HBeAgNegative, Virally Suppressed Patients with Chronic HBV Infection Leads to Deeper Declines in HBsAg and Potential Association with IL28b
| | | | | Reported by Jules Levin
AASLD: The Liver Meeting® 2017, October 20-24, 2017, Washington, DC
KoshAgarwal 1, Ed Gane2, Wendy Cheng 3, William Sievert 4, Stuart Roberts 5, Sang HoonAhn6, Yoon Jun Kim 7, Adrian Streinu-Cercel8, Jill Denning 9, William Symonds 9, Patricia Mendez 9
1 King's College Hospital Foundation Trust, United Kingdom; 2Auckland Clinical Studies Limited, Auckland, New Zealand; 3Royal Perth Hospital and Linear Research, Perth, Australia; 4Monash Health and Monash University, Melbourne, Australia; 5The Alfred, Melbourne, Australia; 6Yonsei University College of Medicine, Seoul, South Korea; 7Seoul National University College of Medicine, Seoul, South Korea; 8Carol Davila University of Medicine and Pharmacy, National Institute for Infectious Diseases "Prof. Dr. MateiBals", Bucharest, Romania; 9Arbutus Biopharma Corporation, Burnaby, Canada.
| | |
|  | |
|
|
